Clinical Trial

Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh

Recruiting
View on ClinicalTrials.gov →
Summary
Metabolic dysfunction-associated fatty liver disease (MAFLD) is an increasingly recognized cause of chronic liver disease and is closely linked with obesity, metabolic abnormalities, and nutritional status. Data on the frequency of MAFLD and its associated metabolic and nutritional factors in rural populations of Bangladesh are not up to date. This study aims to determine the frequency of MAFLD and to evaluate its association with nutritional status and metabolic risk factors among adults in a rural population of Bangladesh. Eligible participants will undergo clinical assessment, anthropometric measurements, laboratory evaluation of metabolic parameters, and abdominal ultrasonography for the detection of hepatic steatosis. Nutritional status will be assessed using standard anthropometric and clinical criteria. The findings of this study are expected to provide baseline epidemiological data on MAFLD in rural Bangladesh and to help identify associated metabolic and nutritional risk factors.
Trial Details
NCT Number NCT07470749
Lead Sponsor Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Collaborators: Bangladesh Medical University
Conditions MAFLD, Metabolic Abnormalities, Obesity & Overweight
Enrollment 1,000 participants
Start Date 2025-12-04
Primary Completion 2026-10 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-13